When it comes to treating epilepsy, each patient needs a custom tailored regimen because the difference between a therapeutic dose and a toxic one is very small. A recent Medgadget article discussed a new breath test that can quickly determine the optimal drug treatment approach for each patient. The test was developed by researchers at Switzerland’s University of Basel, and it helps outline metabolic hallmarks to help clinicians determine the efficacy of a medication.
New Breath Test Determines Epilepsy Drug Regimen
Researchers in Switzerland have developed a breathalyzer test for anti-seizure medications.
Aug 17, 2021
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More